Di Silverio F - Search Results

1

Characterization of circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients.

Sciarra A, Lichtner M, Autran GA, Mastroianni C, Rossi R, Mengoni F, Cristini C, Gentilucci A, Vullo V, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Prostate. 2007 Jan 1;67(1):1-7. doi: 10.1002/pros.20431. Prostate. 2007. PMID: 17075798

2

Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma.

Sciarra A, Monti S, Gentile V, Mariotti G, Cardi A, Voria G, Lucera R, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Prostate. 2003 May 15;55(3):168-79. doi: 10.1002/pros.10222. Prostate. 2003. PMID: 12692782 Clinical Trial.

3

Role of radical retropubic prostatectomy in patients with locally advanced prostate cancer: the influence of Gleason score 8-10.

Sciarra A, Gentile V, Voria G, Mariotti G, Seccareccia F, Pastore A, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Urol Int. 2003;70(3):186-94. doi: 10.1159/000068777. Urol Int. 2003. PMID: 12660455

4

Combination therapy of ethinylestradiol and somatostatin analogue reintroduces objective clinical responses and decreases chromogranin a in patients with androgen ablation refractory prostate cancer.

Di Silverio F, Sciarra A. Di Silverio F, et al. J Urol. 2003 Nov;170(5):1812-6. doi: 10.1097/01.ju.0000092480.71873.26. J Urol. 2003. PMID: 14532782

5

Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.

Sciarra A, Cardi A, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Urol Int. 2004;72(2):91-8. doi: 10.1159/000075960. Urol Int. 2004. PMID: 14963347 Review.

6

Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma.

Sciarra A, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Urology. 2004 Mar;63(3):523-7. doi: 10.1016/j.urology.2003.10.043. Urology. 2004. PMID: 15028450 Clinical Trial.

7

Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancer.

Cerulli C, Sciarra A, Salvatori G, Di Silverio F. Cerulli C, et al. Among authors: di silverio f. Urology. 2004 Dec;64(6):1231.e1-3. doi: 10.1016/j.urology.2004.06.066. Urology. 2004. PMID: 15596212

8

Inflammation and chronic prostatic diseases: evidence for a link?

Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V. Sciarra A, et al. Among authors: di silverio f. Eur Urol. 2007 Oct;52(4):964-72. doi: 10.1016/j.eururo.2007.06.038. Epub 2007 Jul 2. Eur Urol. 2007. PMID: 17618043 Review.

9

Etoricoxib and intermittent androgen deprivation therapy in patients with biochemical progression after radical prostatectomy.

Di Silverio F, Sciarra A, Gentile V. Di Silverio F, et al. Urology. 2008 May;71(5):947-51. doi: 10.1016/j.urology.2007.09.033. Epub 2008 Feb 15. Urology. 2008. PMID: 18279940 Clinical Trial.

10

Biopsy-derived Gleason artifact and prostate volume: experience using ten samples in larger prostates.

Sciarra A, Autran Gomez A, Salciccia S, Dattilo C, Ciccariello M, Gentile V, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Urol Int. 2008;80(2):145-50. doi: 10.1159/000112604. Epub 2008 Mar 19. Urol Int. 2008. PMID: 18362483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters